Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for “Best Overall Mental Health Solution”

4 weeks ago

This marks the fourth consecutive year that Castle has earned a MedTech Breakthrough Award for its innovative testing solutionsFRIENDSWOOD, Texas--(BUSINESS…

TruBridge Announces First Quarter 2024 Results

4 weeks ago

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the first quarter ended March…

Veradigm Payerpath Rated Highest in Client Satisfaction for Small Physician Practice Clearinghouse Services, 2024 Black Book Survey

4 weeks ago

TAMPA, FL / ACCESSWIRE / May 10, 2024 / Black Book Research's annual poll of over 13,000 medical practice IT…

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

4 weeks ago

STONY BROOK, NY / ACCESSWIRE / May 10, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in…

The Plus SideZ: Ozempic Health & Wellness Educational Podcast Records Live Episode

4 weeks ago

Podcast Hosts TikTok Ozempic Creator Community Meet-UpATLANTA, GA / ACCESSWIRE / May 10, 2024 / The Plus Sidez: Cracking the…

Moderna Announces Update on Investigational RSV Vaccine

4 weeks ago

U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by…

NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City

4 weeks ago

SHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum…

Optimi Health Provides Corporate Update

4 weeks ago

VANCOUVER, British Columbia, May 10, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or…

Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

4 weeks ago

WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology…

Genflow Biosciences PLC Announces Holding(s) in Company

4 weeks ago

LONDON, UK / ACCESSWIRE / May 10, 2024 / TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW…